423 related articles for article (PubMed ID: 12424661)
1. [Hepatocellular carcinoma: Role of imaging diagnostics in detection, intervention and follow-up].
Vogl TJ; Eichler K; Zangos S; Mack M; Hammerstingl R
Rofo; 2002 Nov; 174(11):1358-68. PubMed ID: 12424661
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic imaging of hepatocellular carcinoma. Examination technique, results and indications].
Vogl TJ; Hammerstingl R; Schwarz W
Radiologe; 2001 Oct; 41(10):895-905. PubMed ID: 11715581
[TBL] [Abstract][Full Text] [Related]
3. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.
Lim HS; Jeong YY; Kang HK; Kim JK; Park JG
AJR Am J Roentgenol; 2006 Oct; 187(4):W341-9. PubMed ID: 16985104
[TBL] [Abstract][Full Text] [Related]
4. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
5. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
6. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).
Zangos S; Eichler K; Balzer JO; Straub R; Hammerstingl R; Herzog C; Lehnert T; Heller M; Thalhammer A; Mack MG; Vogl TJ
Eur Radiol; 2007 Feb; 17(2):553-63. PubMed ID: 16896704
[TBL] [Abstract][Full Text] [Related]
7. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Dill-Macky MJ; Asch M; Burns P; Wilson S
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
[TBL] [Abstract][Full Text] [Related]
9. The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma.
Sakr AA; Saleh AA; Moeaty AA; Moeaty AA
Eur J Radiol; 2005 Jun; 54(3):418-25. PubMed ID: 15899345
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hepatocellular carcinoma in the cirrhotic liver].
Hourmand-Ollivier I; Chiche L
J Chir (Paris); 2004 Mar; 141(2):71-83. PubMed ID: 15133430
[TBL] [Abstract][Full Text] [Related]
11. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation.
Hunt SJ; Yu W; Weintraub J; Prince MR; Kothary N
J Vasc Interv Radiol; 2009 Jan; 20(1):30-8. PubMed ID: 19028117
[TBL] [Abstract][Full Text] [Related]
12. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
[TBL] [Abstract][Full Text] [Related]
13. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
[TBL] [Abstract][Full Text] [Related]
14. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
Cascales Campos P; Ramirez P; Gonzalez R; Febrero B; Pons JA; Miras M; Sanchez Bueno F; Robles R; Parrilla P
Transplant Proc; 2011; 43(6):2213-5. PubMed ID: 21839236
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
16. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
19. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.
Pleguezuelo M; Germani G; Marelli L; Xiruochakis E; Misseri M; Manousou P; Arvaniti V; Burroughs AK
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):761-84. PubMed ID: 19090737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
